Meeting Banner
Abstract #5109

APT-CEST post Gadolinium. Should it be avoided? Comparison of pre- & post-Gadolinium CEST on glioma at 3T.

Francisco Torrealdea1, Joe Hearle2, Vincent Evans1, Moritz Zaiss3, Ana Carvalho4, Anath Shankar5, Harpreet Hyare4, David Atkinson1, Xavier Golay4, Anna Barnes4, and Marilena Rega4

1Centre for Medical Imaging, UCL, london, United Kingdom, 2Medical school, UCL, london, United Kingdom, 3High Field Magnetic Resonance, Max Plank Institute, Tubinghen, United Kingdom, 4Institute of Nuclear Medicine, UCLH, London, United Kingdom, 5Teenage Cancer Unit, UCLH, london, United Kingdom

This study compares APT-CEST between pre- and post-gadolinium in patients with gliomas at 3T, and evaluates the feasibility of performing CEST after administration of T1 contrast. The results of the study demonstrate that Gd administration does not significantly affect the quality of the APT-CEST image, encouraging the acquisition of CEST data, even after the administration of T1 contrast agents.

This abstract and the presentation materials are available to members only; a login is required.

Join Here